MicroRNA-132 targets HB-EGF upon IgE-mediated activation in murine and human mast cells

Viktor Molnár1, Barbara Érsek, Zoltán Wiener

  • 1Department of Genetics, Cell and Immunobiology, Semmelweis University, Budapest, Hungary. molvik.dgci@gmail.com

Insights

This study reveals microRNA (miRNA) expression changes during mast cell activation. Upregulated miR-132 negatively regulates HB-EGF production in activated mast cells.

Area of Science:

  • Immunology
  • Molecular Biology
  • Gene Regulation

Background:

  • MicroRNAs (miRNAs) are key post-transcriptional regulators of gene expression.
  • Understanding miRNA dynamics during mast cell differentiation and activation is crucial for immunology research.

Purpose of the Study:

  • To investigate microRNA expression profiles during mast cell differentiation and activation.
  • To identify specific miRNAs involved in regulating mast cell responses, particularly IgE-mediated activation.

Main Methods:

  • Microarray analysis of 567 mouse miRNAs in various mast cell populations (progenitors, mucosal mast cells, bone marrow-derived mast cells).
  • Validation of miRNA expression in human mast cells.
  • Luciferase reporter assays to confirm miRNA-target interactions.
  • Inhibition of miRNA activity using anti-miR inhibitors.

Main Results:

  • Significant changes in miRNA expression were observed during mast cell differentiation and activation.
  • miR-132 showed strong upregulation upon IgE-mediated activation in both mouse and human mast cells.
  • HB-EGF (Heparin-binding EGF-like growth factor) was identified as a target of miR-132.
  • miR-132 directly targets and negatively regulates HB-EGF protein production in activated mast cells.

Conclusions:

  • This study identifies a novel negative regulatory mechanism of growth factor production by an upregulated miRNA in mast cells.
  • miR-132 plays a significant role in controlling HB-EGF levels during mast cell activation, offering new insights into mast cell biology.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.